These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10318528)

  • 1. Drug regulation in Canada. Proceedings of the Symposium on Medico-legal Questions in the Pharmaceutical Industry, April 20, 1977, Ontario.
    Leg Med Q; 1977 Dec; 1(4):242-62. PubMed ID: 10318528
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigational new drugs and product liability. Proceedings of the Symposium on Medico-legal Questions in the Pharmaceutical Industry, April 20, 1977, Toronto.
    Leg Med Q; 1977 Sep; 1(3):162-86. PubMed ID: 10318527
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmaceutical industry -- will Canada become a major research centre?
    Gray C
    Can Med Assoc J; 1981 Apr; 124(7):910, 914-5, 918 concl. PubMed ID: 7214290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Swiss pharmaceutical legislation].
    GIRARDET ME
    Prod Pharm; 1960 Mar; 15():130-1. PubMed ID: 13828130
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal risk and its implications. Proceedings of the NCEHR National Workshop on Minimal Risk, March 31-April 1, 2000 held in Ottawa, Ontario, Canada.
    Anderson JA; Weijer C
    NCEHR Commun; 2001 Sep; 11(1):15-26. PubMed ID: 15540386
    [No Abstract]   [Full Text] [Related]  

  • 6. American Pharmaceutical Association House of Delegates, May 13-18 1978, Montreal, Quebec, Canada. Report of the Policy Committe on Public Affairs.
    Am Pharm; 1978 Jul; 18(8 Spec No):22-9. PubMed ID: 665504
    [No Abstract]   [Full Text] [Related]  

  • 7. The doctor and the pharmaceutical industry.
    Girdwood RH
    Br J Clin Pract; 1973 Aug; 27(8):279-84. PubMed ID: 4148588
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
    Garbutt BJ; Hofmann ME
    Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558
    [No Abstract]   [Full Text] [Related]  

  • 9. American Pharmaceutical Association House of Delegates, May 13-18, 1978, Montreal, Quebec, Canada. Report of the Policy Committee on Organizational Affairs.
    Am Pharm; 1978 Jul; 18(8 Spec No):32-5. PubMed ID: 665505
    [No Abstract]   [Full Text] [Related]  

  • 10. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drugs and the patient's health.
    Woods D
    Can Med Assoc J; 1974 Dec; 111(11):1269 passim. PubMed ID: 4154804
    [No Abstract]   [Full Text] [Related]  

  • 12. [Patent rights in pharmacy].
    Madeuf MC
    Farmaco Prat; 1968 May; 23(5):227-37. PubMed ID: 5712398
    [No Abstract]   [Full Text] [Related]  

  • 13. Health geography in 'Steel City': selected papers from the XIII International Medical Geography Symposium, Hamilton, Ontario, Canada, July 2009.
    Andrews GJ; Elliott SJ
    Soc Sci Med; 2011 Feb; 72(3):317-8. PubMed ID: 21220182
    [No Abstract]   [Full Text] [Related]  

  • 14. Considerations for developing an antiarrhythmic agent: a perspective from the pharmaceutical industry.
    Antonaccio MJ
    Can J Cardiol; 1994 Apr; 10(3):325-6. PubMed ID: 8162528
    [No Abstract]   [Full Text] [Related]  

  • 15. The patient package insert. Is it safe and effective?
    Dorsey R
    JAMA; 1977 Oct; 238(18):1936-9. PubMed ID: 578554
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Drug antisubstitution laws: further comment.
    Hussey HH
    JAMA; 1975 Apr; 232(4):381. PubMed ID: 1173134
    [No Abstract]   [Full Text] [Related]  

  • 17. Inspections: the international regulatory view--Japan.
    Kamura S
    PDA J Pharm Sci Technol; 1994; 48(4):182-3. PubMed ID: 7804816
    [No Abstract]   [Full Text] [Related]  

  • 18. Innovation and drug reimportation: cost, value, and tradeoffs - economic, legal, and public policy implications. Proceedings of an University of Michigan Center for Medication Use, Policy and Economics symposium. April 18-20, 2004. Washington, DC, USA.
    Manag Care; 2004 Jun; 13(6 Suppl):3-44. PubMed ID: 15457644
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings of the conference on residency education in the clinical specialties held at Queen's University, Kingston, Ontario October 1 and 2, 1965 under the sponsorship of the Royal College of Physicians and Surgeons of Canada. Introduction.
    Botterell EH
    Can Med Assoc J; 1966 Oct; 95(14):695-6. PubMed ID: 5922899
    [No Abstract]   [Full Text] [Related]  

  • 20. [What should a medical health officer know about the law regulations concerning pharmacists].
    Aye E
    Offentl Gesundheitswes; 1969 Oct; 31(10):477-98. PubMed ID: 4252924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.